Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Delayed hypersensitivity to house dust-storage mites Thyrophagus putrescentiae in experimental allergic dermatoses].
Biulleten' eksperimental'noi biologii i meditsiny·1992
[Experimental study of the allergenic activity of the pollen of Cyclachena xanthifolia].
Biulleten' eksperimental'noi biologii i meditsiny·1980
[Comparative study of the toxic, anaphylactoid, and sensitizing properties of 5-sulfo-8-mercaptoquinolinates of metals of the 8th and 3d groups of the periodic table].
Biulleten' eksperimental'noi biologii i meditsiny·1980
[Toxic, anaphylactoid, and sensitizing properties of mercaptoquinolinates, metals of the 8th and 3d group].
Biulleten' eksperimental'noi biologii i meditsiny·1980
[Hormonal stimulation of reproductive function in swine].
Fiziologicheskii zhurnal·1993
[Pathogenesis of atherosclerosis in diabetes mellitus. The role of insulin resistance and hyperinsulinemia].
Fiziologicheskii zhurnal·1993
[Informative aspects of interaction between regulatory peptides and cellular membranes].
Fiziologicheskii zhurnal·1993
[EFFect of alpha-ketoglutarate and acetylcholine synergism on energy metabolism in mitochondria].
Fiziologicheskii zhurnal·1993
Aptamer-based nanoparticle drug delivery system designed for targeting GPC3-positive liver cancer.
Journal of pharmaceutical analysis·2026
Structure-informed characterization of a TLR2-binding scFv reveals a CDR-centered recognition model.
Biochemical and biophysical research communications·2026
Safety assessment of the substance 1,3-benzenedicarboxamide, 5-[[[cis-4-(1,1-dimethylethyl)cyclohexyl]carbonyl]amino]-N1,N3-bis[cis-4-(1-methylethyl)cyclohexyl]- for use in food contact materials.
EFSA journal. European Food Safety Authority·2026
Systems pharmacology, structural modeling, and experimental validation reveal retinoic acid as a modulator of immune-fibrotic networks in chronic kidney disease.
Naunyn-Schmiedeberg's archives of pharmacology·2026
New paradigm of q-CAR drug development targeting disease-specific protein conformations.
npj drug discovery·2026